David Salzman
Seminars
Wednesday 20th August 2025
Unveiling GHB1589: A Precision Oligo Therapy for the Treatment of IPF
12:00 pm
- Presenting GHB1589, a precision microRNA replacement therapy with potential application across seven fibrotic diseases, including IPF
- Tracing its journey from target discovery, based on analysis of over 3,100 human subjects, through to preclinical research findings
- Showcasing a blood-based biomarker assay designed to identify patients with low microRNA expression, enabling a precision treatment approach
